PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.52%
Negative revenue growth while Insurance - Life median is 0.05%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-2.52%
Negative gross profit growth while Insurance - Life median is 0.07%. Seth Klarman would suspect poor product pricing or inefficient production.
1.18%
EBIT growth of 1.18% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
1.18%
Operating income growth exceeding 1.5x Insurance - Life median of 0.69%. Joel Greenblatt would see if unique processes drive exceptional profitability.
4.36%
Net income growth of 4.36% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.
4.36%
EPS growth of 4.36% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
4.35%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 0.07%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.00%
OCF growth exceeding 1.5x Insurance - Life median of 0.00%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
1.00%
FCF growth exceeding 1.5x Insurance - Life median of 0.00%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
105.95%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 75.19%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
105.95%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 54.01%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
76.15%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 19.28%. Joel Greenblatt might see a short-term competitive advantage at play.
122.81%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 63.56% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
122.81%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 26.04%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
406.20%
3Y OCF/share growth > 1.5x Insurance - Life median of 21.48%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
206.95%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
206.95%
5Y net income/share CAGR > 1.5x Insurance - Life median of 94.30%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
124.66%
3Y net income/share CAGR > 1.5x Insurance - Life median of 75.07%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
225.10%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 42.84% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
225.10%
5Y equity/share CAGR > 1.5x Insurance - Life median of 65.46%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
182.71%
3Y equity/share CAGR > 1.5x Insurance - Life median of 33.16%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.75%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-2.15%
Negative BV/share change while Insurance - Life median is 0.79%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
48.05%
Debt growth of 48.05% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
2.24%
SG&A growth of 2.24% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.